.Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J07A_BacterialVaccines.J07AF01_DiphtheriaToxoid.DiphtheriaToxoid .Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J07A_BacterialVaccines.J07AF01_DiphtheriaToxoid.DiphtheriaToxoid| name: | DiphtheriaToxoid | |
| ATC code: | J07AF01 | |
| route: | intramuscular | |
| compartments: | 1 | |
| dosage: | 0.5 | mg |
| volume of distribution: | 1 | L |
| clearance: | 0 | |
| other parameters in model implementation | ||
Diphtheria toxoid is an inactivated toxin derived from Corynebacterium diphtheriae used as an antigen in vaccines to provide immunization against diphtheria, a serious bacterial infection. It is widely used in childhood and adult vaccine formulations such as DTP (diphtheria-tetanus-pertussis) and remains an approved immunization agent worldwide.
No peer-reviewed publication was found reporting detailed pharmacokinetic parameters of diphtheria toxoid in humans. As a protein antigen vaccine administered intramuscularly, absorption is believed to occur via lymphatic uptake, with slow release from the site of injection and immune processing rather than classic distribution/elimination as seen with small molecule drugs. Standard doses are administered in healthy pediatric and adult populations.